0,705  0,006  Antineoplastic (cervical cancer)
0,640  0,005  Antineoplastic (carcinoma)
0,588  0,037  Antineoplastic (breast cancer)
0,541  0,063  Apoptosis agonist
0,524  0,051  Caspase 9 stimulant
0,452  0,026  Lipoxygenase inhibitor
0,445  0,021  Hypoxia-inducible factor 1 alpha inhibitor
0,470  0,050  Antibacterial
0,385  0,041  Cardioprotectant
0,372  0,035  DNA damaging
0,370  0,038  Antineoplastic (non-small cell lung cancer)
0,385  0,055  Antiallergic
0,391  0,066  Antileukemic
0,332  0,009  NADPH oxidase inhibitor
0,347  0,025  Sedative
0,373  0,059  Prostate cancer treatment
0,350  0,039  Proliferative diseases treatment
0,345  0,037  Antineoplastic (glioblastoma multiforme)
0,352  0,045  Antineoplastic (glioma)
0,352  0,053  Antineoplastic (melanoma)
0,314  0,016  Topoisomerase II inhibitor
0,340  0,045  Cytotoxic
0,339  0,049  UGT1A9 substrate
0,341  0,053  CTGF expression inhibitor
0,339  0,056  Spasmolytic
0,343  0,063  Antifungal
0,327  0,053  Antioxidant
0,334  0,062  Antimycobacterial
0,331  0,061  NOS3 expression inhibitor
0,312  0,043  Mutagenic
0,404  0,137  Antiinflammatory
0,276  0,014  Alkylator
0,342  0,081  CYP3A4 substrate
0,287  0,026  Pneumotoxic
0,330  0,071  Antineoplastic (colorectal cancer)
0,301  0,043  Antineoplastic (bladder cancer)
0,317  0,059  Antineoplastic (small cell lung cancer)
0,322  0,066  Antineoplastic (ovarian cancer)
0,361  0,109  Calcium channel L-type activator
0,314  0,071  Antineoplastic (colon cancer)
0,245  0,019  Antifungal enhancer
0,320  0,094  CYP2C9 substrate
0,305  0,079  AR expression inhibitor
0,280  0,057  Free radical scavenger
0,310  0,089  Transcription factor NF kappa B inhibitor
0,278  0,066  Chemoprotective
0,284  0,073  Antituberculosic
0,259  0,049  Nitric oxide antagonist
0,285  0,076  Ca2+/calmodulin-dependent kinase II alpha inhibitor
0,293  0,085  Hepatic disorders treatment
0,285  0,085  Antidepressant
0,268  0,069  Antineoplastic (renal cancer)
0,261  0,062  Cytostatic
0,285  0,087  Caspase 3 stimulant
0,258  0,064  Antineoplastic (lymphoma)
0,261  0,067  Antineoplastic (liver cancer)
0,215  0,023  Topoisomerase I inhibitor
0,200  0,011  Contraceptive male
0,242  0,054  RNA-directed DNA polymerase inhibitor
0,257  0,070  NOS2 expression inhibitor
0,210  0,025  DNA polymerase I inhibitor
0,288  0,105  Antineoplastic (lung cancer)
0,217  0,037  Contraceptive
0,274  0,099  Mood disorders treatment
0,214  0,044  UGT1A3 substrate
0,245  0,077  Antidiabetic symptomatic
0,224  0,059  Chemopreventive
0,223  0,059  UGT1A1 substrate
0,167  0,005  Cathepsin L2 inhibitor
0,185  0,023  MAP3K9 inhibitor
0,180  0,018  Topoisomerase II alpha inhibitor
0,212  0,057  UGT2B7 substrate
0,211  0,059  Hepatoprotectant
0,177  0,030  5-Lipoxygenase inhibitor
0,229  0,084  Antiprotozoal (Leishmania)
0,247  0,103  Respiratory analeptic
0,278  0,136  Histamine release inhibitor
0,185  0,048  Protein kinase stimulant
0,160  0,025  Antineoplastic alkaloid
0,192  0,057  Antimutagenic
0,241  0,107  CYP1A2 substrate
0,173  0,040  Monophenol monooxygenase inhibitor
0,181  0,048  Antineoplastic (squamous cell carcinoma)
0,174  0,044  Skin whitener
0,164  0,037  DNA intercalator
0,253  0,139  Ulceration
0,190  0,077  UDP-glucuronosyltransferase substrate
0,187  0,074  P-glycoprotein inhibitor
0,184  0,072  Antiviral (Hepatitis)
0,228  0,117  Anxiolytic
0,214  0,105  Antineoplastic (sarcoma)
0,151  0,046  Antihemorrhagic
0,225  0,122  Antihypoxic
0,158  0,062  Genotoxic
0,164  0,068  Antiviral (Herpes)
0,217  0,124  Analeptic
0,200  0,107  Antihypotensive
0,156  0,065  Lipid peroxidase inhibitor
0,179  0,090  Amyloid beta aggregation inhibitor
0,192  0,105  Antiamyloidogenic
0,156  0,071  UGT2B9 substrate
0,160  0,075  Antiviral (Hepatitis C)
0,225  0,146  Antineoplastic (osteosarcoma)
0,159  0,080  UGT1A4 substrate
0,211  0,134  Antineoplastic (multiple myeloma)
0,127  0,053  Cystathionine beta-synthase inhibitor
0,184  0,112  Antineoplastic (lymphocytic leukemia)
0,123  0,054  Photosensitizer
0,080  0,011  Acetyl-CoA transferase 2 inhibitor
0,190  0,123  Hypoglycemic
0,117  0,051  Electron transport complex I inhibitor
0,105  0,043  SULT1E1 substrate
0,139  0,079  Antiprotozoal (Coccidial)
0,136  0,078  Mannose-6-phosphate isomerase inhibitor
0,071  0,013  Pregnane X receptor antagonist
0,102  0,045  Antineoplastic antibiotic
0,160  0,104  Antirickettsial
0,191  0,136  DNA synthesis inhibitor
0,263  0,210  5 Hydroxytryptamine release inhibitor
0,127  0,074  Antiacne
0,214  0,162  Apoptosis antagonist
0,125  0,074  Antineoplastic (uterine cancer)
0,092  0,042  NAD(P)H dehydrogenase (quinone) inhibitor
0,174  0,125  VCAM1 expression inhibitor
0,195  0,149  UGT2B4 substrate
0,109  0,066  Mucolytic
0,051  0,009  Melatonin 1 agonist
0,149  0,107  Platelet adhesion inhibitor
0,169  0,128  UGT1A6 substrate
0,126  0,086  Psychosexual dysfunction treatment
0,218  0,179  Immunosuppressant
0,190  0,152  CYP2D6 substrate
0,165  0,129  VEGF expression inhibitor
0,163  0,128  Aldehyde oxidase inhibitor
0,098  0,064  Carbonic anhydrase III inhibitor
0,046  0,012  Melatonin 2 agonist
0,064  0,032  Protein kinase C eta inhibitor
0,123  0,092  UGT2B15 substrate
0,076  0,047  Telomerase inhibitor
0,134  0,105  Aldose reductase substrate
0,098  0,071  Expectorant
0,160  0,137  Antineoplastic enhancer
0,039  0,016  Melatonin agonist
0,068  0,046  Andropause treatment
0,177  0,161  CYP2C19 substrate
0,110  0,096  DNA repair enzyme inhibitor
0,040  0,026  Retinoic acid alpha receptor agonist
0,138  0,125  Lipocortins synthesis antagonist
0,085  0,074  Restless leg syndrome treatment
0,072  0,064  Antitreponemal
0,077  0,070  Androgen antagonist
0,143  0,137  Antihypertriglyceridemic
0,050  0,045  Postmenopausal disorders treatment
0,031  0,029  Retinoid X alpha receptor agonist
0,059  0,056  5 Hydroxytryptamine agonist
0,076  0,074  Antiviral (Trachoma)
0,120  0,119  Prostatic (benign) hyperplasia treatment
0,028  0,028  Estrogen receptor alpha agonist
0,030  0,029  Estrogen-related receptor beta antagonist

